by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials
Conditions: COVID-19; Influenza Interventions: Biological: mCombriax® (mRNA-1083); Biological: Efluelda® (TIV-HD) and Spikevax® (mRNA-1273) Sponsors: Tor Biering-Sørensen; ModernaTX, Inc. Not yet recruiting Conditions: COVID-19; Influenza Interventions: Biological:...
by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials
Conditions: DLBCL; CLL; FL; MCL; WM; MZL Interventions: Drug: BAFF-R CAR-T Sponsors: Institute of Hematology & Blood Diseases Hospital, China; Hebei Taihe Chunyu Biotechnology Co., Ltd Not yet recruiting Conditions: DLBCL; CLL; FL; MCL; WM; MZL Interventions:...
by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials
Conditions: Pregnancy; Post Partum; Doula Care; Postpartum Depression (PPD); Perinatal Depression; Perinatal Anxiety; Health Disparities; Pregnancy Complications; Maternal Adverse Outcomes Interventions: Other: Doula; Other: Standard (non-enhanced) Medicaid doula...
by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials
Conditions: Sickle Cell Disease (SCD) Sponsors: Ain Shams University Recruiting Conditions: Sickle Cell Disease (SCD) Sponsors: Ain Shams University Recruiting
by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials
Conditions: Evaluation of Mainstreamed Models of Genetic Service Delivery; Genetic Disease; Neurodevelomental Disorders Interventions: Genetic: Genome-wide Sequencing Ordering Sponsors: The Hospital for Sick Children Not yet recruiting Conditions: Evaluation of...
